40 reports of this reaction
1.5% of all BUPRENORPHINE AND NALOXONE reports
#19 most reported adverse reaction
DRUG DEPENDENCE is the #19 most commonly reported adverse reaction for BUPRENORPHINE AND NALOXONE, manufactured by Amneal Pharmaceuticals LLC. There are 40 FDA adverse event reports linking BUPRENORPHINE AND NALOXONE to DRUG DEPENDENCE. This represents approximately 1.5% of all 2,589 adverse event reports for this drug.
Patients taking BUPRENORPHINE AND NALOXONE who experience drug dependence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG DEPENDENCE is a less commonly reported adverse event for BUPRENORPHINE AND NALOXONE, but still significant enough to appear in the safety profile.
In addition to drug dependence, the following adverse reactions have been reported for BUPRENORPHINE AND NALOXONE:
The following drugs have also been linked to drug dependence in FDA adverse event reports:
DRUG DEPENDENCE has been reported as an adverse event in 40 FDA reports for BUPRENORPHINE AND NALOXONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG DEPENDENCE accounts for approximately 1.5% of all adverse event reports for BUPRENORPHINE AND NALOXONE, making it a notable side effect.
If you experience drug dependence while taking BUPRENORPHINE AND NALOXONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.